scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1040318597 |
P356 | DOI | 10.1038/MODPATHOL.2009.189 |
P932 | PMC publication ID | 2900582 |
P698 | PubMed publication ID | 20081808 |
P5875 | ResearchGate publication ID | 41041461 |
P50 | author | Markku Miettinen | Q55221582 |
Jerzy Lasota | Q106621949 | ||
P2093 | author name string | Abdul Waheed | |
William S Sly | |||
Jaromir Pastorek | |||
Silvia Pastorekova | |||
Jonathan A Fletcher | |||
Jorma Isola | |||
Seppo Parkkila | |||
Anna-Kaisa Parkkila | |||
Wen-Bin Ou | |||
Jyrki Ollikainen | |||
Kyösti Nuorva | |||
Antti J Kivelä | |||
P2860 | cites work | Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors | Q24669676 |
Identification of carbonic anhydrase XII as the membrane isozyme expressed in the normal human endometrial epithelium | Q28141313 | ||
A novel quasi-viral agent, MaTu, is a two-component system | Q28209256 | ||
Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis | Q28272917 | ||
Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapy | Q30802745 | ||
Carbonic anhydrases: current state of the art, therapeutic applications and future prospects | Q34361209 | ||
Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. | Q34506729 | ||
Gastrointestinal stromal tumor (GIST). | Q34571507 | ||
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors | Q34587617 | ||
DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases | Q34609954 | ||
Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal | Q34747216 | ||
CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. | Q34751646 | ||
Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro | Q35051535 | ||
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status | Q35102879 | ||
Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. | Q35746400 | ||
Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal | Q35746422 | ||
Neuromuscular structures in opossum esophagus: role of interstitial cells of Cajal | Q36624177 | ||
KIT mutations in GIST. | Q36701593 | ||
Gastrointestinal stromal tumors and leiomyosarcomas | Q37089121 | ||
Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours | Q37099095 | ||
Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. | Q39899643 | ||
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications | Q40783216 | ||
Protein kinase C theta is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias. | Q44951995 | ||
Protein Kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs). | Q45003972 | ||
Molecular characterisation of soft tissue tumours: a gene expression study | Q57245633 | ||
Carbonic anhydrase isoenzymes II and I are present in the zona glomerulosa cells of the human adrenal gland | Q70648368 | ||
Immunohistochemical demonstration of human carbonic anhydrase isoenzyme II in brain tumours | Q71492049 | ||
An immunohistochemical and clinicopathological study of gastrointestinal stromal tumors | Q73036770 | ||
The expression of carbonic anhydrase II in hematological malignancies | Q74453186 | ||
Distribution of the interstitial cells of Cajal in the human anorectum | Q77715068 | ||
Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation | Q78175155 | ||
P433 | issue | 5 | |
P921 | main subject | biomarker | Q864574 |
P304 | page(s) | 743-750 | |
P577 | publication date | 2010-01-15 | |
P1433 | published in | Modern Pathology | Q15724578 |
P1476 | title | Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors | |
P478 | volume | 23 |
Q36369656 | A rare giant gastrointestinal stromal tumor of the stomach traversing the upper abdomen: a case report and literature review |
Q41069286 | Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor |
Q47965507 | Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia. |
Q52678989 | Carbonic Anhydrases: Role in pH Control and Cancer. |
Q40320773 | Carbonic anhydrase II: a novel biomarker for pseudomyxoma peritonei. |
Q91826315 | Carbonic anhydrase IX and acid transport in cancer |
Q38177264 | Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors |
Q37284494 | Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas. |
Q34905520 | Contribution of intestinal smooth muscle to Crohn's disease fibrogenesis |
Q33861624 | Crossing borders to bind proteins--a new concept in protein recognition based on the conjugation of small organic molecules or short peptides to polypeptides from a designed set |
Q33797159 | Detection of autoantibodies against carbonic anhydrase I and II in the plasma of patients with gastric cancer |
Q39254783 | Down regulation of CAII is associated with tumor differentiation and poor prognosis in patients with pancreatic cancer |
Q43743612 | From in situ to in vivo: an in situ click-chemistry-derived carbonic anhydrase II imaging agent for positron emission tomography |
Q82948349 | Gastrointestinal stromal tumors |
Q39036173 | Gastrointestinal stromal tumors (GISTs): SEAP-SEOM consensus on pathologic and molecular diagnosis. |
Q37888736 | Gastrointestinal stromal tumours--an update for histopathologists |
Q58603976 | Gigantic GIST: A Case of the Largest Gastrointestinal Stromal Tumor Found to Date |
Q36804902 | Identification of potential biomarkers from microarray experiments using multiple criteria optimization |
Q47292108 | Insights into the Proteome of Gastrointestinal Stromal Tumors-Derived Exosomes Reveals New Potential Diagnostic Biomarkers. |
Q37933052 | Interfering with pH regulation in tumours as a therapeutic strategy |
Q42169333 | Intracellular carbonic anhydrase activity sensitizes cancer cell pH signaling to dynamic changes in CO2 partial pressure. |
Q34501774 | Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients |
Q55380924 | Network Pharmacology-Based Approach to Investigate the Mechanisms of Hedyotis diffusa Willd. in the Treatment of Gastric Cancer. |
Q33833577 | Neurotensin receptor 1 is expressed in gastrointestinal stromal tumors but not in interstitial cells of Cajal |
Q36821619 | Overexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors |
Q36563177 | Reduction of CAII Expression in Gastric Cancer: Correlation with Invasion and Metastasis |
Q57257995 | Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome |
Q38478183 | cDNA-microarray analysis as a new tool to predict lymph node metastasis in gastric cancer. |
Q37790658 | pH control mechanisms of tumor survival and growth |